Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

BACKGROUND: Regular users of aspirin may have reduced risk of breast cancer. Few studies have addressed whether risk reduction pertains to specific breast cancer subtypes defined jointly by hormone receptor (estrogen and progesterone receptor) and human epidermal growth factor receptor 2 (HER2) expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Christina A., Canchola, Alison J., Moy, Lisa M., Neuhausen, Susan L., Chung, Nadia T., Lacey, James V., Bernstein, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410689/
https://www.ncbi.nlm.nih.gov/pubmed/28460643
http://dx.doi.org/10.1186/s13058-017-0840-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410689/
https://www.ncbi.nlm.nih.gov/pubmed/28460643
http://dx.doi.org/10.1186/s13058-017-0840-7

Ejemplares similares